Demographics (1)
- SEX - Gender of participant (phv00167461.v2.p2)
Mental Health (2)
- AFFECTION_STATUS - Case control status of the subject (phv00167449.v2.p2)
- PRIMARY_DISEASE - Primary disease of participant (phv00167462.v2.p2)
Other (16)
- ANALYSIS_CAT - Analysis category (phv00167463.v2.p2)
- ANALYTE_TYPE - Analyte type - all samples are RNA (phv00167468.v2.p2)
- BODY_SITE - Body site where sample was collected - all are LCLs made from peripheral blood (phv00167467.v2.p2)
- CONSENT - Consent group as determined by DAC (phv00167448.v2.p2)
- Coverage_Pass - Samples meeting 80% of targets at 20X coverage (phv00169020.v2.p2)
- HISTOLOGICAL_TYPE - Histological type (phv00167470.v2.p2)
- IS_TUMOR - Tumor status of samples (phv00253772.v1.p2)
- SAMP_SOURCE - Source repository where samples originate (phv00167457.v2.p2)
- SAMPID - Sample ID (phv00167456.v2.p2)
- SAMPID - Sample ID (phv00167466.v2.p2)
- SAMPLE_USE - Sample use. Seq_DNA_SNP_CNV: SNP and CNV genotypes derived from sequence data; Seq_DNA_WholeExome: Whole exome sequencing (phv00167459.v2.p2)
- SITE - Site where sequencing occurred (phv00167464.v2.p2)
- SOURCE_SAMPID - Sample ID used in the Source Repository (phv00167458.v2.p2)
- SUBJID - De-identified subject ID (phv00167460.v2.p2)
- SUBJID - De-identified subject ID (phv00167455.v2.p2)
- SUBJID - Subject ID (phv00167447.v2.p2)